Biohaven Pharma to continue late-stage study of Alzheimer's treatment

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 10:12 PM.

  1. #1 cafead, Dec 6, 2019 at 10:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,013
    Likes Received:
    3
    via Biohaven Pharmaceutical said on Friday it would continue testing its Alzheimer’s disease treatment in a late-stage study as the drug had passed a so-called “futility analysis”, sending shares up 4.1%.

    article source
     
    Quote

Reply to Thread